Cargando…
Current status of traditional Chinese medicine for the treatment of COVID-19 in China
An ongoing outbreak of severe respiratory illness and pneumonia caused by the severe acute respiratory coronavirus 2 (SARS-CoV-2) commenced in December 2019, and the disease was named as coronavirus disease 2019 (COVID-19). Soon after, scientists identified the characteristics of SARS-CoV-2, includi...
Autores principales: | Chu, Liang, Huang, Fang, Zhang, Mengdan, Huang, Biao, Wang, Yigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314260/ https://www.ncbi.nlm.nih.gov/pubmed/34315521 http://dx.doi.org/10.1186/s13020-021-00461-y |
Ejemplares similares
-
Current Status of Standardization of Traditional Chinese Medicine in China
por: Wang, Juan, et al.
Publicado: (2016) -
Current Policies and Measures on the Development of Traditional Chinese Medicine in China
por: Wang, Wan-Ying, et al.
Publicado: (2021) -
Contribution of traditional Chinese medicine to the treatment of COVID-19
por: Wang, Wan-Ying, et al.
Publicado: (2021) -
Combating COVID-19 with integrated traditional Chinese and Western medicine in China
por: Ni, Liqiang, et al.
Publicado: (2020) -
Treatment of COVID-19 by monoclonal antibodies and the traditional Chinese medicine
por: Ling, Yuyan, et al.
Publicado: (2022)